Natasha McKee, PA
Medical · Missoula, MTNPI 1144262734
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 30.1% of the total. Among medical clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$365
- Lilly USA, LLC$336
- Johnson & Johnson$280
- Sanofi$259
- UCB, Inc.$233
- plus $918 from 12 others
What the payments were for
- Food & beverage$3,32097%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 99 | $1,028 |
| Novartis | 19 | $365 |
| Lilly USA, LLC | 18 | $336 |
| Johnson & Johnson | 12 | $280 |
| Sanofi | 12 | $259 |
| UCB, Inc. | 12 | $233 |
| Amgen | 10 | $185 |
| E.r. Squibb & Sons, L.L.C. | 10 | $162 |
| Regeneron Healthcare Solutions, Inc. | 6 | $121 |
| Pfizer | 7 | $96 |
| Sun Pharmaceutical Industries Inc. | 6 | $91 |
| Blueprint Medicines Corporation | 2 | $58 |
| LEO Pharma Inc. | 2 | $44 |
| Dermavant Sciences, Inc. | 2 | $39 |
| Incyte Corporation | 2 | $38 |
| Kyowa Kirin, Inc. | 2 | $36 |
| Galderma Laboratories, L.p. | 2 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
How this compares
$3,419 in reported general payments places this provider in the 90th percentile of 134 medical providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 12 | $75,346 |
| Dupixent PenDupilumab | 14 | $52,176 |
| Fluorouracil | 26 | $1,972 |
| Metronidazole | 29 | $1,157 |
| Clobetasol Propionate | 31 | $570 |
| Triamcinolone Acetonide | 64 | $418 |
| Mometasone Furoate | 24 | $418 |
| Spironolactone | 21 | $329 |
| Doxycycline Monohydrate | 12 | $259 |
| Imiquimod | 11 | $162 |
| SsdSilver Sulfadiazine | 18 | $138 |
| Hydroxychloroquine Sulfate | 19 | $113 |
Paid to pharmacies, not to this prescriber.
Other medical in Missoula
- Heidi DrescherMissoula$6K
- Brianna LuiMissoula$5K
- James PrattMissoula$4K
- Madelyn BoyleMissoula$2K
- Alira SpringMissoula$1K
- Sarianna RembeMissoula$445
- Mackenzie GeorgeKalispell$9K
- David BrostGreat Falls$7K
- Erin LafavorBillings$6K
- Gabriel BlomquistBillings$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.